Anergis: Eva Castagnetti, PhD, has several years of experience in both technical and business management functions in the biopharmaceutical industry with Lonza, Senn Chemicals and Rapid Pharmaceuticals. She has been responsible for the development and production of Active Pharmaceutical Ingredients (peptides) in early to late clinical phases, gaining comprehensive experience of the regulatory and quality requirements in the development of new pharmaceutical products. Eva obtained her PhD in organic chemistry in 2001 from the University of Lausanne/EPFL and spent two years as a postdoctoral fellow at the Massachusetts Institute of Technology (Cambridge/Boston) and at the ETH Zurich.
Multivariate (Human) Systems Analysis. And had a close look at a couple of interesting Technologies Company Name Novartis Dates Employed 2015 – Present Employment Duration 5 yrs Drug Development from preclinical to commercial. CRISPR, RNA, Cell and Gene, Nanoparticles, Biologics, Small Molecules